Evidence map›Paper›PMID 37439166›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2023

[Colorectal cancer cells induce the formation of cancer-associated fibroblasts by activating the ERK signaling pathway in fibroblasts].

T Deng, B DU, X Xi

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

T DengDepartment of Immunology, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, China.
B DUDepartment of Immunology, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, China.
X XiDepartment of Immunology, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, China.
Hubei University of Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the mechanism by which conditioned medium of colorectal cancer cells promotes the formation of cancer-associated fibroblasts (CAFs).

methodsNormal human colorectal fibroblasts (CCD-18Co cells) in logarithmic growth phase were treated with the conditioned media of colorectal cancer HCT116 cells (HCT116-CM) or Caco-2 cells (Caco-2-CM) alone or in combination with 300 nmol/L ERK inhibitor SCH772984. The expression levels of CAFs-related molecular markers were detected in the treated cells with real-time quantitative PCR (RT- qPCR) and immunofluorescence assay, and the changes in cell proliferation, colony formation and migration were assessed with RTCA, colony formation and wound healing assays; Western blotting was performed to detect the activated signaling pathways in the fibroblasts and the changes in CAFs formation after blocking of the signaling pathway.

resultsHCT116-CM and Caco-2-CM significantly upregulated mRNA expression levels of CAFs markers (including

conclusionColorectal cancer cells may induce the formation of colorectal CAFs by activating the ERK pathway in the fibroblasts.

Indexed as

Cancer-Associated FibroblastsColorectal NeoplasmsCaco-2 CellsCell Line, TumorCell MovementCell ProliferationCulture Media, ConditionedFibroblastsHumansMAP Kinase Signaling SystemSignal TransductionCulture Media, Conditionedcancer-associated fibroblastscolorectal cancerERK singalingtumor microenvironment

Identifiers

PMID37439166
PMCPMC10339307
OpenAlexW4384119772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.